Every material Form 8-K Astera Labs filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Astera Labs reported record third-quarter 2025 revenue of $230.6 million, up 20% from the prior quarter and 104% from a year earlier, and GAAP net income of $91.1 million, compared with a net loss of $7.6 million in the third quarter of 2024. The quarter's net income included a GAAP income tax benefit of $24.3 million. The company also guided fourth-quarter revenue to $245 million to $253 million and said it entered a definitive agreement to acquire aiXscale Photonics GmbH.
GAAP diluted EPS of $0.50 and GAAP net income of $91.1 million, versus a net loss of $7.6 million a year earlier
Non-GAAP diluted EPS of $0.49, excluding stock-based compensation expense of $40.7 million in the quarter
Fourth-quarter 2025 outlook: revenue of $245 million to $253 million and GAAP diluted EPS of approximately $0.20
Definitive agreement to acquire aiXscale Photonics GmbH; the filing does not disclose the purchase price
Astera Labs reported second-quarter 2025 revenue of $191.9 million, up 20% from the first quarter and 150% from a year earlier, with GAAP net income of $51.2 million and GAAP diluted earnings per share of $0.29. The company forecast third-quarter 2025 revenue of $203 million to $210 million and GAAP diluted earnings per share of $0.23 to $0.24, which is below the second-quarter GAAP figure. Shareholders get a higher revenue and profit base for the quarter, along with a third-quarter outlook that points to lower GAAP earnings per share than the second quarter reported.
Q2 2025 revenue was $191.9 million, up 20% sequentially and 150% year over year
GAAP net income was $51.2 million, or $0.29 per diluted share, versus $0.18 per diluted share in the prior quarter ended March 31, 2025
Non-GAAP diluted EPS was $0.44 for the quarter; GAAP operating margin was 20.7%
Q3 2025 outlook: revenue of $203 million to $210 million and GAAP diluted EPS of $0.23 to $0.24
Astera Labs reported first-quarter 2025 results for the period ended March 31, 2025, with revenue of $159.4 million, up 13% from the prior quarter and 144% from a year earlier. GAAP net income was $31.8 million, or $0.18 per diluted share, compared with a net loss of $93.0 million a year earlier. The company also guided second-quarter revenue to $170 million to $175 million, which would extend growth for shareholders if achieved.
Q1 2025 revenue of $159.4 million, up 13% sequentially and 144% year-over-year
GAAP net income of $31.8 million and diluted EPS of $0.18, versus a net loss of $93.0 million and EPS of $(1.77) in Q1 2024
Non-GAAP diluted EPS of $0.33 for Q1 2025
Q2 2025 outlook: revenue of $170 million to $175 million; GAAP diluted EPS of $0.10 to $0.11
Astera Labs increased its board from seven to eight members and appointed Dr. Craig Barratt as a director effective March 2, 2025. He also replaced Manuel Alba on the Audit Committee, and the board classed him as independent. The filing describes a routine board addition with a standard director compensation package.
Craig Barratt appointed to the Board effective March 2, 2025; board increased from seven to eight directors
Replaces Manuel Alba on the Audit Committee; Barratt designated a Class II director, expected to stand for election at the 2026 Annual Meeting
Compensation: $60,000 annual Board retainer, $12,500 annual Audit Committee retainer (prorated for 2025), and a one-time RSU award with a fair market value of $330,000 vesting in equal annual installments over three years
Astera Labs reported preliminary fourth-quarter 2024 revenue of $141.1 million, up 25% from the prior quarter and up 179% from a year earlier, and GAAP net income of $24.7 million, or $0.14 per diluted share. For full-year 2024, revenue was $396.3 million, but the company reported a GAAP net loss of $83.4 million, which included $88.9 million of stock-based compensation tied to its IPO. The company also projected first-quarter 2025 revenue of $151 million to $155 million, which would be above the fourth-quarter level.
Q4 2024 revenue of $141.1 million, up 25% sequentially and up 179% year over year; GAAP net income of $24.7 million, or $0.14 per diluted share
Full-year 2024 revenue of $396.3 million, up 242%; GAAP net loss of $83.4 million, or $0.64 per share
Q1 2025 outlook: revenue of $151 million to $155 million; GAAP diluted EPS of $0.03 to $0.04; non-GAAP diluted EPS of $0.28 to $0.29
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Astera Labs filing is on SEC EDGAR ↗. 8-K briefs of other companies →